Skip to main content
Clinical Trials/NCT01543997
NCT01543997
Completed
Phase 2

Investigating Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms: An Exploratory Randomized Controlled Trial

University of Utah2 sites in 1 country75 target enrollmentJanuary 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Sleep Disturbance
Sponsor
University of Utah
Enrollment
75
Locations
2
Primary Endpoint
Change from baseline in the measure of the Sleep Diary
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to investigate clinical benefits of a novel sleep-focused mind-body program on Gulf War Illness (GWI) symptoms.

Detailed Description

This randomized study investigates whether two treatment conditions:Mind-Body Bridging (MBB) and Supportive Education (SED) are effective in improving sleep disturbance and self-reported indicators of other co-morbid symptoms in veterans with GWI. The two treatment conditions will each comprise 3 sessions of 2 hr. duration and conducted over 3 consecutive weeks (Week 1-3).

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
May 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yoshio Nakamura

Research Associate Professor

University of Utah

Eligibility Criteria

Inclusion Criteria

  • Veteran from First Gulf War
  • Suffering from sleep disturbance
  • Has other chronic symptoms of Gulf War Illness:
  • chronic headaches
  • joint/muscle pain
  • cognitive difficulties
  • memory/concentration problems
  • shortness of breath
  • gastrointestinal symptoms

Exclusion Criteria

  • terminally ill
  • a highly unstable medical or psychiatric condition
  • Parkinson disease
  • dementia of any cause
  • delayed/advanced sleep phase syndrome
  • Narcolepsy

Outcomes

Primary Outcomes

Change from baseline in the measure of the Sleep Diary

Time Frame: Week2, Week 4, Week 15

Change from baseline in the measure of the Medical Outcomes Study-Sleep Scale

Time Frame: Week1, Week2, Week 3, Week 4, Week 15

Secondary Outcomes

  • Pain(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • Fatigue(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • Cognitive functioning(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • Mindfulness(Pre (Baseline), Weekly for 3 weeks, Post (Week4), Follow-up (Week 15))
  • Health-related quality of life(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • Depression(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • Psychological symptoms(Pre (Baseline), Post (Week4), Follow-up (Week 15))
  • PTSD(Pre (Baseline), Post (Week4), Follow-up (Week 15))

Study Sites (2)

Loading locations...

Similar Trials